文献速递甲状腺疾病

基因修复部分甲状腺滤泡细胞可恢复DUOXA-/-小鼠甲状腺功能

Genetic Rescue of a Subset of Thyroid Follicular Cells Restores Thyroid Function in Dyshormonogenic Duoxa-/- Mice.
PubMed 文献 · Thyroid · 2025-10-17

在DUOXA-/-小鼠中,通过低剂量他莫昔芬条件性表达DUOXA2/DUOX2,发现每个滤泡仅需11-15%的甲状腺滤泡细胞被重新激活即可恢复碘化甲状腺球蛋白合成;约50-70%的iTG+滤泡足以在两周内恢复健康甲状腺功能,甲状腺肿消退程度与左甲状腺素替代治疗相当。

要点

  • 每个滤泡11-15%的TFC被修复即可功能性恢复碘有机化。
  • 基因修复可使甲状腺肿消退,效果与左甲状腺素替代治疗相当。
  • 基因修复组TSH反应基因和Dio1表达较左甲状腺素组更快正常化。

核心结论

  • 在Duoxa-/-小鼠中,每个滤泡仅需纠正10-15%的TFC即可恢复甲状腺激素合成,提示体细胞基因治疗可行。

研究设计与样本

  • 在Duoxa-/-小鼠中通过条件性甲状腺特异性表达DUOXA2/DUOX2进行基因修复,使用低剂量他莫昔芬(0.1-2 mg)限制部分TFC重新激活。

主要发现

  • 0.1 mg他莫昔芬组表现为原发性先天性甲减未缓解,伴甲状腺增大、Nis/Tpo/Tshr诱导、Dio1下降和生长延迟。
  • 仅11-15%的TFC在滤泡内被重新激活即可功能性恢复碘有机化。
  • 约50-70%的iTG+滤泡似足以在两周内恢复健康甲状腺功能。
  • 基因修复组和左甲状腺素组甲状腺增大程度相似降低,但基因修复组Nis、Tpo、Tshr和Dio1更快速正常化。

关键数值与推荐

  • 多西环素诱导的Tet:Da2D2+/-;mTg:CreERT2+/-;Duoxa-/-动物(3TA)中超过90%滤泡显示胶质iTG+染色。
  • 他莫昔芬0.1 mg导致原发性先天性甲减未缓解。
  • 每个滤泡需重新激活11-15%的TFC以功能性恢复碘有机化。
  • 约50-70%的iTG+滤泡似足以在两周内恢复健康甲状腺功能。

临床怎么用

  • 为未来针对甲状腺滤泡细胞的体细胞基因治疗提供概念验证,提示只需纠正少部分细胞即可恢复功能。
  • 基因修复在甲状腺肿消退和功能指标正常化方面与左甲状腺素替代治疗相当或更快。

局限性

  • 研究为Duoxa-/-小鼠模型,结果向人类先天性甲减的转化需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: Under sufficient iodine supply, dual oxidase (DUOX)-dependent H2O2 production constitutes the limiting factor for thyroid hormone (TH) synthesis. Inherited loss-of-function mutations in related genes can trigger congenital hypothyroidism (CH). TH supplementation is not always well-tolerated and requires dose adjustments throughout life. Regenerative medicine directed at thyroid follicular cells (TFCs) could offer an alternative therapy; however, the minimal number of TFCs to be corrected remains unknown. Methods: Thyroid dyshormonogenesis in Duoxa-/- deficient mice was rescued by conditional thyroid-specific expression of DUOXA2/DUOX2 subunits. In order to restrict reactivation in a subset of TFCs, low doses of tamoxifen (0.1-2 mg) were injected. Thyroid function was assessed by immunostaining of iodinated-thyroglobulin (iTG). Circulating serum thyrotropin (TSH) and total thyroxin (T4) were quantified, and thyroidal expression of TSH-responsive genes (Nis, Tpo, Tshr) and hepatic deiodinase type-1 (Dio1) was measured. Last, combining iTG immunostaining with Duox2 in situ hybridization, we estimated the fraction of rescued TFCs required to restore follicular TG iodination. Results: Colloidal iTG+ staining in more than 90% of follicles demonstrated the successful rescue of TH biogenesis in doxycycline-induced Tet:Da2D2+/-;mTg:CreERT2+/-;Duoxa-/- animals (3TA). In contrast, reducing tamoxifen doses to 0.1 mg resulted in unresolved primary CH with thyroid enlargement, induction of Nis, Tpo, and Tshr, decrease of Dio1, and growth delay. Corresponding thyroid sections revealed scattered iTG+ colloidal lumens dispersed in histologically altered parenchyma. Nevertheless, we determined that only 11-15% of TFCs need to be reactivated within the follicle to functionally restore iodide organification. Goiter involution was also studied in 3TA following functional oxidase recovery or levothyroxine supplementation. Although thyroid enlargement was similarly reduced in both groups, expression of Nis, Tpo, Tshr, and Dio1 more rapidly normalized in genetically rescued 3TA. In these pathological conditions, around 50-70% of iTG+ follicles would seem sufficient to recover a healthy thyroid function until two weeks. Conclusions: Our data in Duoxa-/- mice suggest that the percentage of TFCs to be corrected is limited to 10-15% per follicle, which could be compatible with future somatic gene therapies. Furthermore, the reconstitution of hormonogenic-competent TFCs successfully results in goiter resolution, to an extent comparable to that of gold-standard TH replacement therapy.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Djerbib S, Grasberger H, Goossens S, et al. Genetic Rescue of a Subset of Thyroid Follicular Cells Restores Thyroid Function in Dyshormonogenic Duoxa-/- Mice. Thyroid. 2025. PMID: 41174922. doi:10.1177/10507256251388325

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。